Industry

ATLANTA–(BUSINESS WIRE)–United Musculoskeletal Partners (UMP) announced today its merger with Dallas-based Novum Orthopedic Partners (Novum) to form the premier physician-owned orthopedic platform in the country. In addition, Denver-based Panorama Orthopedics (Panorama) joins Atlanta-based Resurgens Orthopaedics (Resurgens) and Dallas-based Arlington Orthopedic Associates (AOA) as co-founding partners of UMP. Together, these new partnerships establish UMP as a … [Read more…]

Optum survey shows consumer expectations for accessing care have transformed, calling for improvements in the ‘digital front door’ for providers and health plans Consumers reveal opportunities for providers and health plans to modernize care-seeking experiences to attract and retain patients and members. Payers and providers should shore up their websites, portals and mobile applications. Survey … [Read more…]

PEACHTREE CORNERS, Ga.–(BUSINESS WIRE)–#HPV–Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology, announced that it has obtained Institutional Review Board (IRB) approval to initiate its clinical trial aimed at obtaining FDA approval for the Company’s flagship product, the LuViva Advanced … [Read more…]

MADISON, Wis.–(BUSINESS WIRE)–Navitus Health Solutions, an industry-disrupting pharmacy benefit manager (PBM) that’s committed to bringing humanity to pharmacy benefits management through greater transparency and affordability, announced today that Shayna Schulz has joined the company as Chief Operations Officer. Shayna is responsible for providing strategic direction and oversight to the eligibility, claims administration and customer care … [Read more…]

Capital will advance BigHat’s internal pipeline of therapeutics to patients, expand platform capacity 10-fold, and accelerate strategic partnerships SAN MATEO, Calif.–(BUSINESS WIRE)–BigHat Biosciences, a biotechnology company developing safer, more effective antibody therapies for patients using machine learning and synthetic biology, today announced it has raised a $75 million Series B funding round, led by Section … [Read more…]

Clinical study launched in June 2022 with patient recruitment in Alberta with plans to expand to further sites across North America. The aim of the study is to validate a novel and minimally invasive liquid biopsy test for bladder cancer diagnosis using Nanostics’ ClarityDX® diagnostic platform. The study is supported in part by the Alberta … [Read more…]

ELYRIA, Ohio–(BUSINESS WIRE)–Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the second quarter ended June 30, 2022, after the market closes on Monday, August 8, 2022. The company will provide a live conference call and webcast to discuss these financial results on Tuesday, August 9, 2022, … [Read more…]

Jeremy Kean joins the leading customer-centric dental AI company to drive hyper-growth BOSTON–(BUSINESS WIRE)–VideaHealth, the leading dental diagnostic AI solution, today announced the addition of healthcare veteran Jeremy Kean as vice president of customer success. Kean brings more than 20 years of customer success experience to the company’s executive team, including successful tenures at WebMD … [Read more…]

Series B financing will accelerate clinical trials and global commercialization of the company’s Symani® Surgical System PISA, Italy–(BUSINESS WIRE)–Medical Microinstruments, Inc. (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced it has raised $75 million in Series B financing. Deerfield Management led the round with participation from new investors, … [Read more…]

-Top line data expected in second half of 2023- ROCKVILLE, Md.–(BUSINESS WIRE)–#MCC–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of LAMP (Lysosome Associated Membrane Protein)-mediated nucleic acid-based immunotherapy, today announced dosing of the first patient in the company’s Phase 1 study evaluating ITI-3000, a plasmid DNA (pDNA) vaccine targeting patients with … [Read more…]